Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty

NCT: NCT07191067 · RECRUITING

NCT IDNCT07191067
StatusRECRUITING
Start Date2025-09-30
Completion2026-12-31

Brief Summary

Multi-center, randomized, blinded, sham-controlled study to determin the safety and efficacy of the NOVABLOC system on post-operative pain in patients undergoing TKA procedures.

Frequently Asked Questions

What is Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty?

Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty is a clinical trial registered under NCT07191067. Current status: RECRUITING.

What is the status of NCT07191067?

The current status of NCT07191067 (Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty) is: RECRUITING.

When did Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty start?

Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty started on 2025-09-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑